COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
出版年份 2021 全文链接
标题
COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
作者
关键词
-
出版物
Translational Research
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-03-07
DOI
10.1016/j.trsl.2021.03.002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
- (2020) Achille Aouba et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
- (2020) Zhuo Zhou et al. Cell Host & Microbe
- Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
- (2020) Annsea Park et al. Cell Host & Microbe
- Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome
- (2020) Jared Radbel et al. CHEST
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
- (2020) Ruggero Capra et al. European Journal of Internal Medicine
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
- (2020) T. Klopfenstein et al. MEDECINE ET MALADIES INFECTIEUSES
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
- (2020) Franco Locatelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- On the Alert for Cytokine Storm: Immunopathology in COVID ‐19
- (2020) Lauren A. Henderson et al. Arthritis & Rheumatology
- Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
- (2020) Benjamin Israelow et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications
- (2020) Joan T. Merrill et al. Nature Reviews Rheumatology
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- (2020) Alexandre B. Cavalcanti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Is a “Cytokine Storm” Relevant to COVID-19?
- (2020) Pratik Sinha et al. JAMA Internal Medicine
- Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series
- (2020) Iris Navarro‐Millán et al. Arthritis & Rheumatology
- Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions
- (2020) Matthijs Kox et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy
- (2020) Julie Goswami et al. SHOCK
- Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
- (2018) Eric S. Weiss et al. BLOOD
- Convergent pathways of the hyperferritinemic syndromes
- (2018) Grant S Schulert et al. INTERNATIONAL IMMUNOLOGY
- FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
- (2018) Robert Q. Le et al. ONCOLOGIST
- Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis
- (2018) Grant S. Schulert et al. ARTHRITIS CARE & RESEARCH
- Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis
- (2018) Grant S. Schulert et al. Arthritis & Rheumatology
- Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus
- (2018) R. Ezequiel Borgia et al. Arthritis & Rheumatology
- Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
- (2017) Francesca Minoia et al. JOURNAL OF PEDIATRICS
- Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
- (2016) Claudia Bracaglia et al. ANNALS OF THE RHEUMATIC DISEASES
- 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
- (2016) Angelo Ravelli et al. ANNALS OF THE RHEUMATIC DISEASES
- A HeterozygousRAB27AMutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis
- (2016) Mingce Zhang et al. JOURNAL OF IMMUNOLOGY
- 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborat
- (2016) Angelo Ravelli et al. Arthritis & Rheumatology
- Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan
- (2015) Shumpei Yokota et al. ANNALS OF THE RHEUMATIC DISEASES
- Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
- (2015) Grant S. Schulert et al. Annual Review of Medicine
- ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice
- (2015) J. E. Rood et al. BLOOD
- Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ
- (2015) Karen Put et al. RHEUMATOLOGY
- Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
- (2015) Alexei A. Grom et al. Arthritis & Rheumatology
- Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation
- (2014) Neil Romberg et al. NATURE GENETICS
- An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
- (2014) Scott W Canna et al. NATURE GENETICS
- Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
- (2014) Francesca Minoia et al. Arthritis & Rheumatology
- Whole-Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis
- (2014) Kenneth M. Kaufman et al. Arthritis & Rheumatology
- Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome
- (2014) Laurence Fardet et al. Arthritis & Rheumatology
- Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment
- (2012) A Ravelli et al. GENES AND IMMUNITY
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series
- (2010) Peter A. Nigrovic et al. ARTHRITIS AND RHEUMATISM
- Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
- (2010) P. M. Miettunen et al. RHEUMATOLOGY
- Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
- (2009) Sebastiaan J. Vastert et al. RHEUMATOLOGY
- Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms
- (2008) Kejian Zhang et al. ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation